Mirum Pharmaceuticals Q3 Product Sales Total $185.721 Million
Story updates
09:12:24 PM UTC
SquawkNews
Mirum Pharmaceuticals Q3 net product sales surge, outlook raised
Related stories
Kadant Sees 2026 Adjusted EPS of $12.58-$12.73
L impact | EARNINGS | Nov 03, 2026, 09:59 PM UTC
Skyworks Expects Fiscal Q1 Adjusted EPS of $1.25
M impact | EARNINGS | Nov 03, 2026, 09:48 PM UTC
Innospec reports third-quarter EPS of $1.29
L impact | EARNINGS | Nov 03, 2026, 09:45 PM UTC
Corcept Therapeutics Posts Q3 EPS of $1.01
Q3 EPS was $1.01, versus the FactSet estimate of $0.79.
M impact | EARNINGS | Nov 03, 2026, 09:44 PM UTC
Limbach Holdings Q3 Adjusted EPS $1.37 vs. $1.08 Estimate
Limbach Holdings reported Q3 adjusted EPS of USD 1.37, compared with the IBES estimate of USD 1.08.
M impact | EARNINGS | Nov 03, 2026, 09:44 PM UTC
AMD Data Center Revenue Nearly Doubles; Shares Rise 7% After Hours
AMD’s data center revenue nearly doubled, and its shares rose 7% in after-hours trading.
M impact | EARNINGS | Nov 03, 2026, 09:44 PM UTC